Colony-Stimulating Factors
Customize your policy alerts
Sign up for all Mass General Brigham Health Plan policy alerts
Know when Mass General Brigham Health Plan releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs prior authorization for selected granulocyte colony-stimulating factors covered under the medical benefit for MassHealth members. It establishes indication, preferred-product failure or contraindication, medical-necessity, dosing, continuation, and approval-duration requirements.
The policy was created to manage specified colony-stimulating factors under the MassHealth prior authorization program effective January 4, 2027.
Medical-benefit management was assigned to the listed colony-stimulating factors, while some products are also available through the pharmacy benefit.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.